Nitin Kaushal Sells 30,000 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD) Stock

Viemed Healthcare, Inc. (NASDAQ:VMDGet Free Report) Director Nitin Kaushal sold 30,000 shares of the firm’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $9.56, for a total transaction of $286,800.00. Following the completion of the sale, the director now owns 126,843 shares of the company’s stock, valued at $1,212,619.08. This trade represents a 19.13 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Viemed Healthcare Price Performance

VMD opened at $9.06 on Friday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The stock has a market capitalization of $352.80 million, a PE ratio of 33.56 and a beta of 1.43. Viemed Healthcare, Inc. has a 1 year low of $6.21 and a 1 year high of $10.44. The company’s 50 day simple moving average is $8.31 and its 200 day simple moving average is $7.53.

Viemed Healthcare (NASDAQ:VMDGet Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. The company had revenue of $58.00 million for the quarter. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%.

Institutional Investors Weigh In On Viemed Healthcare

Several hedge funds have recently modified their holdings of the stock. Evernest Financial Advisors LLC bought a new stake in Viemed Healthcare during the 2nd quarter valued at approximately $66,000. Perkins Coie Trust Co acquired a new position in Viemed Healthcare in the third quarter worth $73,000. Price T Rowe Associates Inc. MD bought a new stake in Viemed Healthcare during the 1st quarter worth about $97,000. PDT Partners LLC acquired a new stake in shares of Viemed Healthcare in the third quarter valued at approximately $78,000. Finally, Walleye Capital LLC acquired a new stake in shares of Viemed Healthcare in the 3rd quarter valued at $87,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

About Viemed Healthcare

(Get Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

See Also

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.